Georgia will receive an additional one million doses of Pfizer Covid-19 vaccine in the coming months, local media outlets report.
Pfizer is pleased to announce that part of its negotiations with the Georgian government on the supply of over one million doses of Pfizer vaccine has been completed. The company is moving to the part of the signing the agreement with the Georgian government”, the Pfizer management team told to businessformula.ge.
The company has not specified the exact date of Covid-19 vaccine import, nor is it known at what price Georgia will purchase the Pfizer vaccines.
In mid-May Georgian Prime Minister Irakli Garibashvili said that he was personally involved in the process of negotiations and held a number of phone conversations with the president of Pfizer.
The first 29,250 doses of the US-German Pfizer/BioNtech coronavirus vaccine was imported in Georgia at the end of March 2021.
Based on evidence from clinical trials, the Pfizer-BioNtech vaccine is 95 per cent effective at preventing laboratory-confirmed Covid-19 illness in people without evidence of previous infection.
Georgia started coronavirus vaccination in mid-March when the country received the first 43,200 doses of AstraZeneca vaccine.
As of now, Georgia is using AstraZeneca, Pfizer and Sinopharm vaccines for certain groups of people.